EDN1 and glomerulosclerosis: In support of this observation, mitochondrial-targeted ROS scavengers and endothelin antagonists inhibit the release of EDN1, thus reducing mitochondrial oxidative stress and endothelial cell dysfunction, thereby preventing glomerulosclerosis (Daehn et al., 2014).